Role of hemogram-derived ratios in predicting intensive care unit admission in COVID-19 patients: a multicenter study

M D Asaduzzaman1, Mohammad Romel Bhuia2, Zhm Nazmul Alam1

  • 1Department of Medicine, Sylhet MAG Osmani Medical College Hospital, Sylhet-3100, Bangladesh.

IJID Regions
|June 20, 2022
PubMed

Insights

Cost-effective hemogram ratios can predict intensive care unit (ICU) admission in COVID-19 patients. These markers, including the neutrophil-to-lymphocyte ratio, help identify high-risk individuals early.

Area of Science:

  • Medical research
  • Clinical diagnostics
  • Inflammation markers

Background:

  • Hyperinflammation is a key factor in severe COVID-19.
  • Monitoring inflammation markers is crucial for patient management.
  • Hemogram-derived ratios offer a potentially cost-effective approach.

Purpose of the Study:

  • To assess the effectiveness of hemogram-derived ratios in predicting ICU admission for COVID-19 patients.
  • To identify simple, inexpensive laboratory markers for risk stratification.
  • To aid in early identification of patients requiring intensive care.

Main Methods:

  • Multicenter retrospective study of 442 hospitalized COVID-19 patients.
  • Analysis of demographic, clinical, and laboratory data.
  • Logistic regression used to determine the predictive significance of hemogram ratios for ICU admission.

Main Results:

  • 22.17% of patients required ICU admission.
  • ICU patients had higher neutrophil counts and lower lymphocyte/platelet counts.
  • Neutrophil-to-lymphocyte ratio, derived neutrophil-to-lymphocyte ratio, neutrophil-to-platelet ratio, and systemic immune-inflammation index significantly predicted ICU admission.

Conclusions:

  • Hemogram-derived ratios are effective tools for early risk categorization in COVID-19.
  • These ratios facilitate timely interventions for high-risk patients.
  • Cost-effective hemogram markers can improve patient management strategies.
Abstract

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
239
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
42